ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2009;87:618-621. doi:10.1016/j.athoracsur.2008.06.059
© 2009 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Eric Dumont
Daniel Doyle
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clavel, M.-A.
Right arrow Articles by Rodés-Cabau, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Clavel, M.-A.
Right arrow Articles by Rodés-Cabau, J.
Related Collections
Right arrow Valve disease

Case Reports

Severe Valvular Regurgitation and Late Prosthesis Embolization After Percutaneous Aortic Valve Implantation

Marie-Annick Clavel, DVM, Eric Dumont, MD, Philippe Pibarot, PhD, FACC, Daniel Doyle, MD, Robert De Larochellière, MD, Jacques Villeneuve, MD, Sebastien Bergeron, MD, Christian Couture, MD, Josep Rodés-Cabau, MD, FESC*

Quebec Heart Institute/Laval Hospital, Quebec, Canada

Accepted for publication June 17, 2008.

* Address correspondence to Dr Rodés-Cabau, Quebec Heart Institute/Laval Hospital, 2725 Chemin Ste-Foy, Quebec, G1V 4G5, Canada (Email: josep.rodes{at}crhl.ulaval.ca).

We report the case of a 79-year-old man with low-flow, low-gradient aortic stenosis who underwent transapical aortic valve implantation. The deployment of a 26-mm Edwards SAPIEN valve (Edwards Lifesciences Inc, Irvine, CA) was complicated with the occurrence of severe central aortic regurgitation that was successfully treated with the implantation of a second valve ("valve-in-valve"). Postoperative progress was satisfactory but 2 days after the procedure he suddenly developed cardiogenic shock secondary to the migration of the aortic bioprothesis into the left ventricular outflow tract. Open-heart surgery was undertaken to remove the valves and perform standard aortic valve replacement, but the patient died perioperatively.




This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
L. C. Maroto, J. E. Rodriguez, J. Cobiella, and J. Silva
Delayed dislocation of a transapically implanted aortic bioprosthesis
Eur. J. Cardiothorac. Surg., November 1, 2009; 36(5): 935 - 937.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The Society of Thoracic Surgeons.